FAQ's On The Propoxyphene, Darvon, Darvocet Recall

November 19, 2010 | Category: Recalls
On November 19, 2010, the U.S. Food and Drug Administration (FDA) announced that it intends to withdraw propoxyphene from the United States market, because new data indicate this drug may cause serious toxicity to the heart, even when used at therapeutic doses.

Read Full Post

Propoxyphene Recall

November 19, 2010 | Category: Recalls
The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of the pain reliever propoxyphene because new data show that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. FDA has requested that companies voluntarily withdraw propoxyphene from the United States market.

Read Full Post

Darvon and Darvocet Recall

November 19, 2010 | Category: Recalls
Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration.

Read Full Post

Meridia Recall

October 30, 2010 | Category: Recalls
Abbott has issued a Meridia Recall after being asked by the FDA to stop marketing the product in the United States due to results of a study indicating an increased risk of heart attack and stroke in Meridia users.

Read Full Post